Regenstrief aims for interoperability with new method of compiling data

Healthcare interoperability is a goal all health organizations strive to achieve, yet some never do. At the Regenstrief Center for Biomedical Informatics, staff are hoping to ease the process of acheiving interoperability by testing the newly developed method of compiling health data into a single healthcare information system known the Fast Healthcare Interoperability Standard (FHIR).

FHIR will take data from individual electronic medical records with the data stored on the Indiana Network for Patient Care (INPC), to make a single information system. "What we are working on is a first and could have a huge impact on patients whose health information is distributed across multiple electronic systems -- probably the vast majority of the people in the United States," said Titus Schleyer, DMD, PhD, a Regenstrief Institute investigator and Clem McDonald Professor of Biomedical Informatics at Indiana University School of Medicine. "Using FHIR, we can combine information about a specific patient stored in systems developed by different vendors and installed in different healthcare institutions. This brings us much closer to a ‘lingua franca’ for health information, so clinicians finally have complete information available about their patients."

"For example, imagine that you as a patient can use an app on your smart phone to reconcile the multiple lists of medications maintained by several care providers into one authoritative, current list. And then, you can bring that list to your colonoscopy screening appointment for review by your physician prior to the procedure. That is huge, which is why the federal government is also focusing attention on helping patients do that," emphasized Dr. Schleyer. "FHIR helps us create a secure, complete, accessible, and useful set of health information needed by clinicians and patients."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.